Browse Technologies

• 
• 
• 
• 

Vanderbilt researchers have developed a novel combinatorial logic circuit that prevents the propagation of signal glitches such as those caused by radiation-induced transients. The interlocked-feedback circuit accomplishes this without the loss of any speed. The circuit is designed for robustness in both combinatorial and sequential logic applications.

Despite the success of immune checkpoint inhibitors (ICI) like anti-PD-1 in treating other cancers, these therapeutics have not been demonstrated to effectively treat acute myeloid leukemia (AML). Vanderbilt researchers have identified PD-1H as a potential target for treating AML, opening the door for effective therapy using an ICI molecule.

This technology pairs a novel coil design with patient-specific stereotactic frames for precise delivery of focused ultrasound (FUS) during neuromodulation therapies. This innovative methodology enables patients to receive therapy while outside the MR environment and significantly increases the precision of noninvasive neuromodulation techniques, making treatments more accessible and effective.

An assistive device for individuals with upper extremity neuromuscular deficit has been developed by researchers at Vanderbilt. This device is specifically designed for patients having hemiplegia following stroke, incomplete spinal cord injury, multiple sclerosis, and other disabilities and conditions, who may have severe muscle weakness or inability to fully control an upper limb. In order to facilitate use of the upper limb, the patient can wear the device as a substitute for or a supplement to the patient's volitional movement.